Document Detail


Heparin after angioplasty: an unresolved issue?
MedLine Citation:
PMID:  8299638     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Restenosis following coronary angioplasty remains a significant problem. Experimental work suggests that appropriate use of heparin may be beneficial through inhibition of smooth muscle cell proliferation. Possible mechanisms of this effect in various models, are discussed. Limited clinical studies to date, however, have failed to show therapeutic efficacy. Possible reasons for this lack of effect are discussed and the importance of assessing heparin in appropriate clinical trials is emphasized.
Authors:
R S More; M J Brack; A H Gershlick
Related Documents :
17203988 - New treatment options for acute coronary syndromes.
15083598 - Intravenous glycoprotein iib/iiia inhibitors in acute coronary syndromes: lessons from ...
10859038 - Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome with...
8687258 - Prehospital administration of aspirin in patients with unstable angina and acute myocar...
22707158 - Cardiac-generated prostanoids mediate cardiac myocyte apoptosis after myocardial ischae...
16815568 - Congenital complete heart block and maternal connective tissue disease.
Publication Detail:
Type:  In Vitro; Journal Article; Review    
Journal Detail:
Title:  European heart journal     Volume:  14     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1993 Nov 
Date Detail:
Created Date:  1994-03-04     Completed Date:  1994-03-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1543-7     Citation Subset:  IM    
Affiliation:
Academic Department of Cardiology, Glenfield General Hospital, Leicester, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary*
Animals
Heparin / therapeutic use*
Humans
Postoperative Care
Chemical
Reg. No./Substance:
9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Double-blind randomized trial of alteplase versus placebo in patients with chest pain at rest.
Next Document:  High blood pressure and ventricular arrhythmias.